These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 9124166
1. Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias. Wanless RS, Anderson K, Joy M, Joseph SP. Am Heart J; 1997 Apr; 133(4):441-6. PubMed ID: 9124166 [Abstract] [Full Text] [Related]
2. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group. Circulation; 1995 Nov 01; 92(9):2550-7. PubMed ID: 7586356 [Abstract] [Full Text] [Related]
4. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group. Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG. Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395 [Abstract] [Full Text] [Related]
5. Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo. Tendera M, Wnuk-Wojnar AM, Kulakowski P, Malolepszy J, Kozlowski JW, Krzeminska-Pakula M, Szechinski J, Droszcz W, Kawecka-Jaszcz K, Swiatecka G, Ruzyllo W, Graff O. Am Heart J; 2001 Jul 25; 142(1):93-8. PubMed ID: 11431663 [Abstract] [Full Text] [Related]
6. The efficacy of sotalol in preventing postoperative atrial fibrillation: a meta-analysis. Kerin NZ, Jacob S. Am J Med; 2011 Sep 25; 124(9):875.e1-9. PubMed ID: 21854895 [Abstract] [Full Text] [Related]
15. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group. Sung RJ, Tan HL, Karagounis L, Hanyok JJ, Falk R, Platia E, Das G, Hardy SA. Am Heart J; 1995 Apr 25; 129(4):739-48. PubMed ID: 7900626 [Abstract] [Full Text] [Related]
16. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group. Bhandari AK, Anderson JL, Gilbert EM, Alpert BL, Henthorn RW, Waldo AL, Cullen MT, Hawkinson RW, Pritchett EL. Am Heart J; 1992 Aug 25; 124(2):381-6. PubMed ID: 1636582 [Abstract] [Full Text] [Related]
17. Efficacy and proarrhythmia of oral sotalol in pediatric patients. Pfammatter JP, Paul T, Lehmann C, Kallfelz HC. J Am Coll Cardiol; 1995 Oct 25; 26(4):1002-7. PubMed ID: 7560592 [Abstract] [Full Text] [Related]
18. A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. Boriani G, Lubinski A, Capucci A, Niederle R, Kornacewicz-Jack Z, Wnuk-Wojnar AM, Borggrefe M, Brachmann J, Biffi M, Butrous GS, Ventricular Arrhythmias Dofetilide Investigators. Eur Heart J; 2001 Dec 25; 22(23):2180-91. PubMed ID: 11913480 [Abstract] [Full Text] [Related]